PLAN ESTRATÉGICO DE INVESTIGACIÓN
LÍNEAS DE INVESTIGACIÓN
PROYECTOS DE INVESTIGACIÓN
ENSAYOS CLÍNICOS
GRUPOS COOPERATIVOS
COMUNICACIONES A CONGRESOS
PUBLICACIONES
BECAS Y RECURSOS
INVESTIGACIÓN EN OTROS LUGARES
BIBLIOGRAFIA
NUESTROS RESULTADOS

PUBLICACIONES > Año 2009

 

Tissue Antigens. 2009 Dec;74(6):543-4. Epub 2009 Oct 13.

HLA-B*0777 allele differs from B*0707 by a single residue in the antigen binding groove.

Balas A, Planelles D, Sanz GF, Montoro JA, Vicario JL.

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain. abalas.trans@salud.madrid.org

 


Blood. 2009 Nov 12;114(20):4369-72. Epub 2009 Sep 15.

The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.

Paiva B, Vidriales MB, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García de Coca A, de las Heras N, Mateos MV, López-Berges MC, García-Boyero R, Galende J, Hernández J, Palomera L, Carrera D, Martínez R, de la Rubia J, Martín A, González Y, Bladé J, Lahuerta JJ, Orfao A, San-Miguel JF; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Groups.

Collaborators (66)

Modolell A, Prosper F, Besalduch J, Sureda A, Lorente P, Monzó E, Alcalá Muñoz A, Martínez-Martínez R, Hernández-García MT, Palomera L, Bello JL, Terol MJ, Fernández Calvo FJ, García Ruíz JC, Hernández Ribas JA, Ojanguren JM, Vargas Pabón M, Pérez Equiza K, Navarro I, Serena J, Galende del Canto J, Altes A, Abella E, Soler JA, García Frade J, Callis De Nadal M, Ribas García P, Fernández Llavador MJ, García-Boyero R, Herraez R, Subirà M, Rodríguez Fernández L, Hernández-Martín JM, de Arriba F, Ferrer R, Rivas González C, Orero M, Gómez-García JC, León Lara A, Ribera JM, Escoda L, Gardella S, Barez A, Hernández-Ruíz B, Solano F, Ibañez J, Burgaleta C, Butrón R, García-Laraña J, Ortega Rivas F, Martín-Mateos ML, Sánchez-Godoy P, Bargay J, Lahuerta JJ, García Alonso L, Alegre A, González San Miguel JD, De la Rubia J, Conde García E, Pérez-Fernández I, Font Ferré L, Galán P, Martín A, Casado F, Poderos C, Busto MJ.

Hospital Universitario de Salamanca, Salamanca, Spain.

 


Mult Scler. 2009 Nov;15(11):1303-10. Epub 2009 Oct 13.

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.

Pascual AM, Téllez N, Boscá I, Mallada J, Belenguer A, Abellán I, Sempere AP, Fernández P, Magraner MJ, Coret F, Sanz MA, Montalbán X, Casanova B.

Department of Neurology, Hospital Universitario La Fe, Valencia, Spain 

 


J Neurol. 2009 Oct;256(10):1759-61. Epub 2009 May 12.

Mesial temporal sclerosis as a complication of hematologic cancer.

Sivera R, Bataller L, Martínez J, Villanueva V.

PMID: 19434437 [PubMed - indexed for MEDLINE]

 


Haematologica. 2009 Sep;94(9):1282-8.

Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.

Gallardo D, de la Cámara R, Nieto JB, Espigado I, Iriondo A, Jiménez-Velasco A, Vallejo C, Martín C, Caballero D, Brunet S, Serrano D, Solano C, Ribera JM, de la Rubia J,  Carreras E.

Clinical Haematology Department, Institut Català d'Oncologia, Hospital Josep Trueta, Avda. França s/n, Girona, Spain.

 


  

Leuk Res. 2009 Sep;33(9):e162-3. Epub 2009 Apr 16.

Absence of mutations in the tyrosine kinase and juxtamembrane domains of C-FMS gene in chronic myelomonocytic leukemia (CMML).

Such E, Cervera J, Valencia A, Garcia-Casado Z, Senent ML, Sanz MA, Sanz GF.

PMID: 19375163 [PubMed - indexed for MEDLINE]

 


Leukemia. 2009 Sep;23(9):1658-66. Epub 2009 Apr 23.

Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.

Valencia A, Román-Gómez J, Cervera J, Such E, Barragán E, Bolufer P, Moscardó F, Sanz GF, Sanz MA.

Department of Hematology, Hospital Universitario La Fe, Valencia, Spain.

 


 

J Mol Diagn. 2009 Sep;11(5):458-63. Epub 2009 Jul 30.

Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis.

Fuster O, Barragán E, Bolufer P, Cervera J, Larráyoz MJ, Jiménez-Velasco A, Martínez-López J, Valencia A, Moscardó F, Sanz MA.

Laboratory of Molecular Biology, Department of Medical Pathology, Escuela de enfermería 7 planta. Hospital Universitario La Fe, Avd. Campanar 21, Valencia 46009, Spain.

 


 

Curr Opin Oncol. 2009 Nov;21(6):594-600.

FLT3 inhibition as a targeted therapy for acute myeloid leukemia.

Sanz M, Burnett A, Lo-Coco F, Löwenberg B.

Hematology Service, University Hospital La Fe, Valencia, Spain. msanz@uv.es

 


Med Oncol. 2009 Aug 8. [Epub ahead of print]

High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA.

Aljurf M, Al Qurashi F, Al Mohareb F, Sahovic E, Al Sharif F, Al Zahrani H, Al Shanqeeti A, Owaidah T, Iqbal A, Zaidi SZ, Nurgat ZA, Sanz M, Chaudhri N.

King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh, 11211, Saudi Arabia, maljurf@kfshrc.edu.sa.

 


 

J Clin Oncol. 2009 Sep 20;27(27):4578-84. Epub 2009 Aug 24.

Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.

Bosch F, Abrisqueta P, Villamor N, Terol MJ, González-Barca E, Ferra C, González Diaz M, Abella E, Delgado J, Carbonell F, García Marco JA, Escoda L, Ferrer S, Monzó E, González Y, Estany C, Jarque I, Salamero O, Muntañola A, Montserrat E.

Department of Hematology, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. fbosch@clinic.ub.es

 


Haematologica. 2009 Sep;94(9):1242-9. Epub 2009 Jul 16.

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.

Montesinos P, Díaz-Mediavilla J, Debén G, Prates V, Tormo M, Rubio V, Pérez I, Fernández I, Viguria M, Rayón C, González J, de la Serna J, Esteve J, Bergua JM, Rivas C, González M, González JD, Negri S, Brunet S, Lowenberg B, Sanz MA.

Hematology Department, Hospital Universitario La Fe, Avda. Campanar 21, Valencia, Spain.

Comment in:

Haematologica. 2010 Jan; 95(1): 171-2

Haematologica. 2010 Jan; 95(1): 169-71

 

Biol Blood Marrow Transplant. 2009 Jun;15(6):730-40. Epub 2009 Apr 11.

Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.

Montesinos P, Sanz J, Cantero S, Lorenzo I, Martín G, Saavedra S, Palau J, Romero M, Montava A, Senent L, Martínez J, Jarque I, Salavert M, Córdoba J, Gómez L, Weiss S, Moscardó F, de la Rubia J, Larrea L, Sanz MA, Sanz GF.

Department of Hematology, Hospital Universitario La Fe, Valencia, Spain. montesinos_pau@gva.es

 


 

Haematologica. 2009 Jun;94(6):827-32.

Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.

Moscardó F, Sanz J, Senent L, Cantero S, de la Rubia J, Montesinos P, Planelles D, Lorenzo I, Cervera J, Palau J, Sanz MA, Sanz GF.

Department of Hematology, Hospital Universitario La Fe, Valencia, Spain.

  


 

J Clin Oncol. 2009 Jun 1;27(16):2668-76. Epub 2009 May 4.

Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.

Kelaidi C, Chevret S, De Botton S, Raffoux E, Guerci A, Thomas X, Pigneux A, Lamy T, Rigal-Huguet F, Meyer-Monard S, Chevallier P, Maloisel F, Deconinck E, Ferrant A, Fegueux N, Ifrah N, Sanz M, Dombret H, Fenaux P, Adès L.

European APL Group, L'Institut National de la Santé et de la Recherche Médicale U848, Villejuif, France.

Comment in:

 J Clin Oncol. 2010 Jan 10; 28(2): e21; author reply e22-3.

 


Adv Hematol. 2009;2009:187125. Epub 2009 Jul 28.

Complex Variant t(9;22) Chromosome Translocations in Five Cases of Chronic Myeloid Leukemia.

Valencia A, Cervera J, Such E, Barragán E, Bolufer P, Fuster O, Collado R, Martínez J, Sanz MA.

Department of Hematology, La Fe University Hospital, 46009 Valencia, Spain.

 


 

Med Clin (Barc). 2009 Apr 11;132(13):507-21. Epub 2009 Apr 5.

[Treatment of fungal infections in patients with hematologic neoplasia]

[Article in Spanish]

Mensa J, De La Cámara R, Carreras E, Cuenca Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA.

Sociedad Española de Quimioterapia, Madrid, España. jmensa@clinic.ub.es

PMID: 19345963 [PubMed - indexed for MEDLINE]

 


 

Biol Blood Marrow Transplant. 2009 Apr;15(4):512-6. Epub 2009 Feb 12.

Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.

de la Rubia J, Montesinos P, Martino R, Jarque I, Rovira M, Vázquez L, López J, Batlle M, de la Cámara R, Juliá A, Lahuerta JJ, Debén G, Díaz J, García R, Sanz MA.

Hospital La Fe, Valencia, Spain.

 


Transfusion. 2009 Apr;49(4):813.

Fatal hemolytic disease of the fetus and newborn possibly due to anti-Jr.

Arriaga F, Gomez I, Linares MD, Gascon A, Carpio N, Perales A.

PMID: 19335378 [PubMed - indexed for MEDLINE]

 


 J Clin Oncol. 2009 Jan 10;27(2):256-63. Epub 2008 Dec 8.

Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.

Rodrigues CA, Sanz G, Brunstein CG, Sanz J, Wagner JE, Renaud M, de Lima M, Cairo MS, Fürst S, Rio B, Dalley C, Carreras E, Harousseau JL, Mohty M, Taveira D, Dreger P, Sureda A, Gluckman E, Rocha V.

Eurocord / ARTM-Hôpital Saint Louis, 1, Av Claude Vellefaux, 75475 Paris Cedex 10 France. celsoarrais@uol.com.br

Erratum in:

J Clin Oncol. 2009 Apr 10;27(11):1923.

 

 


 

Rev Iberoam Micol. 2009 Mar 31;26(1):75-7. Epub 2009 May 7.

[Micafungin in invasive candidiasis among oncohematological patients]

[Article in Spanish]

Jarque I, Angel Sanz M.

Hospital Universitario La Fe, Valencia, España. jarque_isi@gva.es

 


  

Blood. 2009 Mar 12;113(11):2386-93. Epub 2008 Nov 12.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN.

Department of Hematology, San Bortolo Hospital, Vicenza, Italy. rodeghiero@hemato.ven.it

Comment in:

Blood. 2009 Aug 27; 114(9): 2003-4; author reply 2004.

 

 


  

Lancet Oncol. 2009 Mar;10(3):223-32. Epub 2009 Feb 21.

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group.

Collaborators (77)

Durrant S, Enno A, Herrmann R, Horvath N, Mills A, Spencer A, Szer J, Gallo J, Dunlop L, Arthur C, Goranov S, Peytchev D, Gercheva L, Cermak J, Voglova J, Vey N, Dreyfus F, Laurent G, Quesnel B, Dombret H, Stamatoullas A, Wattel E, Hunault-Berger M, Aul C, Giagounidis A, Duhrsen U, Gattermann N, Platzbecker U, Schmid M, Hanel M, Haase D, Fiedler W, Schmitz N, Hofmann W, Horst H, Anagnostopoulos N, Pappa V, Papadaki E, Zoumbos N, Borbenyi Z, Masszi T, Baccarani M, Bacigalupo A, Corradini P, Leone G, Sacchi S, Bosi A, Musto P, Muus P, Dmoszynska A, Robak T, Sulek K, Kuliczkowski K, Jedrzejczak W, Zaritsky A, Abdulkadyrov K, Podoltseva E, Afanasiev B, Bargay J, Brunet S, Del Canizo C, Ribera J, Figuera Alvarez A, Diaz-Mediavilla J, Canales M, Ramos y Ortega F, Nilsson L, Olsson A, Cavenagh J, Parker J, Killick S, Kruger A, Vyas P, Dennis M, Cripe L, DiPersio J, Emanuel P.

Hôpital Avicenne, Université Paris XIII, Bobigny, France.

Comment in:

 Lancet Oncol. 2009 Mar; 10(3): 200-1

 


Leuk Lymphoma. 2009 Feb;50(2):216-22.

Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial.

Blanes M, de la Rubia J, Lahuerta JJ, González JD, Ribas P, Solano C, Alegre A, Sanz MA.

Hematology Service, University Hospital La Fe, Valencia, Spain.

 


Leukemia. 2009 Mar;23(3):492-500. Epub 2009 Jan 8.

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.

Willemze R, Rodrigues CA, Labopin M, Sanz G, Michel G, Socié G, Rio B, Sirvent A, Renaud M, Madero L, Mohty M, Ferra C, Garnier F, Loiseau P, Garcia J, Lecchi L, Kögler G, Beguin Y, Navarrete C, Devos T, Ionescu I, Boudjedir K, Herr AL, Gluckman E, Rocha V; Eurocord-Netcord and Acute Leukaemia Working Party of the EBMT.

Clinical Research Unit, Eurocord Office, APHP, Hôpital Saint Louis, Université de Paris VII, Paris, France. r.willemze@lumc.nl

Erratum in:

Leukemia. 2009 Mar;23(3):630.

 


 

Ann Hematol. 2009 Oct;88(10):973-8. Epub 2009 Feb 11.

Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment.

Alvarez-Larrán A, del Río-Garma J, Pujol M, de la Rubia J, Hernández-Jodra M, Borrell M, González-Porras JR, García-Gala JM, Viejo A, Enríquez L, Arbona C, García-Erce JA, Noblejas AG, Pereira A.

Hospital del Mar, Barcelona, Spain

 


 

Blood. 2009 Feb 26;113(9):1875-91. Epub 2008 Sep 23.

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, Burnett AK, Lo-Coco F.

University Hospital La Fe, Valencia, Spain. msanz@uv.es

 


Blood. 2009 Jan 22;113(4):775-83. Epub 2008 Oct 22.

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.

Montesinos P, Bergua JM, Vellenga E, Rayón C, Parody R, de la Serna J, León A, Esteve J, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA.

Hospital Universitario La Fe, Valencia, Spain

 


 

Rev Iberoam Micol. 2009;Suppl:3-199.

[Pocket guide to invasive mycoses in onco-hematologic patients]

[Article in Spanish]

Bermúdez A, Carreras E, De la Cámara R, Eraso E, Fortún J, García-Ruiz JC, Guarro J, Jarque I, Marcos de Lucas E, Mayayo E, Pastor FJ, Pemán J, Pontón J, Quindós G, Salavert M, Sanz MA, Zaragoza R.

Departamento de Hematología, Hospital Universitario Marqués de Valdecilla, Santander.

PMID: 20143497 [PubMed - indexed for MEDLINE]

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Secretaría del Servicio de Hematología · Hospital General, Planta Baja · Hospital Universitario La Fe · Avda. Campanar 21 · 46021 Valencia. · Tfno.:963 862 745 · Fax: 961 973 281
Aviso legal · Mapa web
[X] Cerrar